Risk Factors for Renal Function Impairment Following Radiofrequency Ablation of Renal Tumors

다국어 초록 (Multilingual Abstract)

Purpose To evaluate the various factors that affect renal function following percutaneous radiofrequency ablation (RFA) therapy in patients with renal tumors.
Materials and Methods Between 2010 and 2018, 91 patients diagnosed with renal tumors using ultrasonography and CT-guided RFA were enrolled. We retrospectively investigated the serum creatinine (SCr) level and estimated glomerular filtration rates immediately prior to RFA and during post-treatment follow-up. The patients were divided into two groups based on the degree of change in SCr level (0.3 mg/dL). Group comparisons were performed using univariable and multivariable logistic regression analyses to determine the factors impacting renal function.
Results Impaired renal function was associated with solitary kidney, chronic kidney disease (CKD) over stage 3, and pyeloureteral injury. Sex, age, other cancers, tumor size, location, growth pattern, and proximity to the collecting system were not significantly associated with impaired renal function. There was a difference in the overall change over time between the association with and without solitary kidney, CKD stage 3, and pyeloureteral injury.
Conclusion Among the medical conditions present prior to RFA, solitary kidney and CKD over stage 3 could be considered as risk factors for impaired renal function. Post-procedural pyeloureteral injury can also be considered a risk factor.

참고문헌 (Reference)

1 Park SY, "Thermal ablation in renal cell carcinoma : what affects renal function?" 28 : 729-734, 2012

2 Kutikov A, "The R. E. N. A. L. nephrometry score : a comprehensive standardized system for quantitating renal tumor size, location and depth" 182 : 844-853, 2009

3 Campbell S, "Renal mass and localized renal cancer : AUA guideline" 198 : 520-529, 2017

4 Patel HD, "Renal functional outcomes after surgery, ablation, and active surveillance of localized renal tumors : a systematic review and meta-analysis" 12 : 1057-1069, 2017

5 Lucas SM, "Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques" 179 : 75-79, 2008

6 Takaki H, "Radiofrequency ablation versus radical nephrectomy : clinical outcomes for stage T1b renal cell carcinoma" 270 : 292-299, 2014

7 Chang X, "Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma : long-term clinical and oncologic outcomes based on a propensity score analysis" 29 : 518-525, 2015

8 Gervais DA, "Radiofrequency ablation of renal cell carcinoma : part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors" 185 : 64-71, 2005

9 김수동 ; 윤성국 ; 성경탁, "Radiofrequency Ablation of Renal Tumors: Four-Year Follow-Up Results in 47 Patients" 대한영상의학회 13 (13): 625-633, 2012

10 박성훈 ; 윤성국 ; 조진한 ; 오종영 ; 남경진 ; 권희진 ; 김수연 ; 강명진 ; 최순섭 ; 성경택, "Radiofrequency Ablation Treatment for Renal Cell Carcinoma: Early Clinical Experience" 대한영상의학회 9 (9): 340-347, 2008

11 Chang X, "Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma : long-term clinical and oncologic outcomes" 193 : 430-435, 2015

12 Pettus JA, "Percutaneous radiofrequency ablation does not affect glomerular filtration rate" 24 : 1687-1691, 2010

13 Rivero JR, "Partial nephrectomy versus thermal ablation for clinical stage T1 renal masses : systematic review and meta-analysis of more than 3, 900 patients" 29 : 18-29, 2018

14 Uhlig J, "Partial nephrectomy versus ablative techniques for small renal masses : a systematic review and network meta-analysis" 29 : 1293-1307, 2019

15 Nandanan N, "Outcomes and predictors of benign histology in patients undergoing robotic partial or radical nephrectomy for renal masses : a multicenter study" 73 : 33-38, 2020

16 Zagoria RJ, "Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas" 189 : 429-436, 2007

17 Turna B, "Minimally invasive nephron sparing management for renal tumors in solitary kidneys" 182 : 2150-2157, 2009

18 Pierorazio PM, "Management of renal masses and localized renal cancer : systematic review and meta-analysis" 196 : 989-999, 2016

19 Marshall HR, "Long-term survival after percutaneous radiofrequency ablation of pathologically proven renal cell carcinoma in 100 patients" 31 : 15-24, 2020

20 Yang R, "Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors : initial functional and oncologic outcomes" 28 : 4-9, 2014

21 Motzer RJ, "Kidney cancer, version 2. 2017, NCCN clinical practice guidelines in oncology" 15 : 804-834, 2017

22 Kellum JA, "KDIGO clinical practice guideline for acute kidney injury" 2 : 1-138, 2012

23 Wehrenberg-Klee E, "Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease" 23 : 41-45, 2012

24 Ahmed M, "Image-guided tumor ablation : standardization of terminology and reporting criteria--a 10-year update" 273 : 241-260, 2014

25 Altunrende F, "Image guided percutaneous probe ablation for renal tumors in 65 solitary kidneys : functional and oncological outcomes" 186 : 35-41, 2011

26 Eckardt KU, "Evolving importance of kidney disease : from subspecialty to global health burden" 382 : 158-169, 2013

27 Ljungberg B, "European association of urology guidelines on renal cell carcinoma : the 2019 update" 75 : 799-810, 2019

28 Larcher A, "Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma" 34 : 383-389, 2016

29 Sung HH, "Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size-and location-matched renal masses" 28 : 227-234, 2012

30 Thompson RH, "Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses" 67 : 252-259, 2014

31 Go AS, "Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization" 351 : 1296-1305, 2004

32 Huang WC, "Chronic kidney disease after nephrectomy in patients with renal cortical tumours : a retrospective cohort study" 7 : 735-740, 2006

33 김해진 ; 박병관 ; 박정재 ; 김찬교, "CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes" 대한영상의학회 17 (17): 763-770, 2016

34 Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation. Modification of diet in renal disease study group" 130 : 461-470, 1999

35 Faddegon S, "A comparison of long term renal functional outcomes following partial nephrectomy and radiofrequency ablation" 20 : 6785-6789, 2013